Medical management of glaucoma in the 21st century from a Canadian perspective

P Harasymowycz, C Birt, P Gooi… - Journal of …, 2016 - Wiley Online Library
Glaucoma is a medical term describing a group of progressive optic neuropathies
characterized by degeneration of retinal ganglion cells and retinal nerve fibre layer and …

Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review

G Reardon, S Kotak, GF Schwartz - Patient preference and …, 2011 - Taylor & Francis
Purpose This study summarizes findings from objective assessments of compliance (or
adherence) and persistence with ocular hypotensive agents in patients with glaucoma and …

Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up

RE Craven, JL Katz, JM Wells… - Journal of Cataract & …, 2012 - journals.lww.com
PURPOSE: To assess the long-term safety and efficacy of a single trabecular micro-bypass
stent with concomitant cataract surgery versus cataract surgery alone for mild to moderate …

Determinants of medication adherence to topical glaucoma therapy

LE Dreer, C Girkin, SL Mansberger - Journal of glaucoma, 2012 - journals.lww.com
Methods One hundred sixteen patients with ocular hypertension or open-angle glaucoma
from 2 tertiary glaucoma services participated in this prospective study. Adherence to ocular …

Effects of a novel selective EP2 receptor agonist, omidenepag isopropyl, on aqueous humor dynamics in laser-induced ocular hypertensive monkeys

M Fuwa, CB Toris, S Fan, T Taniguchi… - Journal of Ocular …, 2018 - liebertpub.com
Purpose: To investigate the mechanism of the intraocular pressure (IOP)-lowering effect of a
novel selective prostaglandin E2 receptor 2 (EP2) receptor agonist, omidenepag isopropyl …

Medication adherence in patients with ocular hypertension or glaucoma

AL Robin, KW Muir - Expert Review of Ophthalmology, 2019 - Taylor & Francis
Introduction: Nonadherence to medication is a challenge to effective treatment of many
chronic diseases, including glaucoma, and persists even with interventions aimed at …

Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice

G Holló, F Topouzis, RD Fechtner - Expert Opinion on …, 2014 - Taylor & Francis
Introduction: Several large, randomized, prospective clinical trials have demonstrated that
medical therapy to reduce intraocular pressure (IOP) delays the onset and decreases …

The Japan Glaucoma Society guidelines for glaucoma 5th edition

Y Kiuchi, T Inoue, N Shoji, M Nakamura… - Japanese Journal of …, 2023 - Springer
We are pleased to bring you the 5th edition of the Glaucoma Clinical Practice Guidelines.
Clinical practice guidelines are based on evidence (scientific grounds). It is a document that …

Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study

MV Boland, DS Chang, T Frazier, R Plyler… - JAMA …, 2014 - jamanetwork.com
Importance Adherence with topical glaucoma medications is low in some patients. To
identify these patients, we need more information on risk factors for nonadherence …

[HTML][HTML] Adherence to fixed-combination versus unfixed travoprost 0.004%/timolol 0.5% for glaucoma or ocular hypertension: a randomized trial

HS Barnebey, AL Robin - American journal of ophthalmology, 2017 - Elsevier
Purpose To assess adherence to treatment with fixed-combination travoprost 0.004%/timolol
0.5%(TTFC) compared with separate containers of travoprost 0.004% and timolol …